無料プレビュー

Elanco Animal Health Incorporated (ELAN) · New York Stock Exchange

プロフィール

Elanco Animal Health is a global pharmaceutical company that innovates and delivers products and services to prevent and treat disease in farm animals and pets across more than 90 countries. The company offers a diverse portfolio of approximately 200 branded products for pet health (parasiticides, dermatology, vaccines, pain management) and farm animals (cattle, poultry, swine, sheep), marketed through a global sales force to veterinarians, distributors, retailers and producers. Elanco operates as a single reportable segment with major geographic presence in the U.S., Brazil, the U.K., and Chi

主要指標

株価: $22.54 (+0.81%)
時価総額: 113億ドル
PER（今期予想）: 19.8
PBR: 1.7
配当利回り: —
52週レンジ: $19.40 – $27.98
業種: Healthcare / Drug Manufacturers - Specialty & Generic
上場: New York Stock Exchange
構成銘柄: —

比較会社: MRK Merck & Co., Inc.、TAK Takeda Pharmaceutical Company Limited、TEVA Teva Pharmaceutical Industries Limited、HLN Haleon plc、IDXX IDEXX Laboratories, Inc.、ZTS Zoetis Inc.、VTRS Viatris Inc.、ITCI Intra-Cellular Therapies, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-06 · 更新: 2026-10-09